Healthcare & Life Sciences

Escient Pharmaceuticals

United Stateswww.escientpharma.com/
acquiredacquired
Sign in to unlockWebsite
acquired
Stage

About

Escient Pharmaceuticals is a clinical-stage biopharmaceutical company developing first-in-class, oral small-molecule therapeutics targeting Mas-related G protein-coupled receptors for neurosensory-inflammatory disorders including chronic urticaria and cholestatic pruritus.

Explore Escient Pharmaceuticals's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing